Clinical Trial Update: Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 and Phase 3 testing evaluating drug sensitivity in ovarian, fallopian tube, and primary peritoneal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Pierian Biosciences | Conditions: Adenocarcinoma, Ovarian Neoplasms | Phase 2, Phase 3 | Status: COMPLETED